The present invention relates to a method of inhibiting a protein or tyrosine kinase in vitro, the method comprising contacting a cell comprising one or more of MET, ALK, ROS1, AXL, TRKs, or JAKs with a compound of formula (IV) or a pharmaceutically acceptable salt thereof.